BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 11, 2009
View Archived Issues
Cytokinetics Is All Muscle: Ends Cancer Deal with GSK
A year after GlaxoSmithKline plc backed away from two cancer drugs covered under its collaboration with Cytokinetics Inc., the big pharma handed back rights to the third and final compound as well. (BioWorld Today)
Read More
New Trial a Show of Confidence for Oncothyreon Cancer Vaccine
Read More
Plaques, Bad Cholesterol Get Partial Rehab in Alzheimer's
Read More
Despite Concerns, Panel Backs Gilead Inhaled Aztreonam in CF
Read More
Financings Roundup
Read More
Other News To Note
Read More
Clinic Roundup
Read More